• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL MANUFACTURING CORPORATION LIFEVEST WCD 4000 SYSTEM; WEARABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number LIFEVEST WCD 4000 SYSTEM
Device Problem Insufficient Information (3190)
Patient Problem Shock from Patient Lead(s) (3162)
Event Date 10/30/2022
Event Type  Injury  
Manufacturer Narrative
The monitor and electrode belt have been returned to the distributor.The evaluations have not yet been completed.Based on the data available at this time, there is no indication of a device malfunction causing or contributing to the delivery of an external defibrillation.
 
Event Description
Patient received 2 appropriate shocks during ventricular tachycardia (vt) at 210 bpm.The arrhythmias were converted to a slower rhythm of 70 bpm.The lifevest detected vt at 210 bpm for a third time.The response buttons were pressed delaying the treatment.At 34 seconds into the detection sequence an external defibrillation was delivered.The patient was in the hospital prior to, during and after the treatments.No allegation of a death or serious injury.The patient continues to wear the lifevest.
 
Manufacturer Narrative
Correction: the initial report was filed in error.The distributor has provided corrected information as documented in b3 and b5.There was no adverse event during the appropriate treatments and no intervention.The adverse event has been reported in mfr.Report ref # (b)(4).
 
Event Description
Patient received 2 appropriate shocks during vt at 220 and 210 bpm.The arrhythmias were converted to a slower rhythm.No adverse event or patient injury was reported.Patient received 2 appropriate shocks during ventricular tachycardia (vt) at 210 bpm.The arrhythmias were converted to a slower rhythm of 70 bpm.The lifevest detected vt at 210 bpm for a third time.The response buttons were pressed delaying the treatment.At 34 seconds into the detection sequence an external defibrillation was delivered.The patient was in the hospital prior to, during and after the treatments.No allegation of a death or serious injury.The patient continues to wear the lifevest.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIFEVEST WCD 4000 SYSTEM
Type of Device
WEARABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA 15238
Manufacturer (Section G)
ZOLL MANUFACTURING CORPORATION
121 gamma drive
pittsburgh PA
Manufacturer Contact
zoll mfg corporation
121 gamma drive
pittsburgh, PA 15238
MDR Report Key15779319
MDR Text Key303556539
Report Number3008642652-2022-25444
Device Sequence Number1
Product Code MVK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P010030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberLIFEVEST WCD 4000 SYSTEM
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 11/03/2022
Initial Date FDA Received11/11/2022
Supplement Dates Manufacturer Received11/03/2022
Supplement Dates FDA Received11/14/2022
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-